| Cardioprotective HIF-1α-frataxin signaling against ischemia-reperfusion injury G Nanayakkara, A Alasmari, S Mouli, H Eldoumani, J Quindry, ... American Journal of Physiology-Heart and Circulatory Physiology 309 (5 …, 2015 | 69 | 2015 |
| The role of frataxin in doxorubicin-mediated cardiac hypertrophy S Mouli, G Nanayakkara, A AlAlasmari, H Eldoumani, X Fu, A Berlin, ... American Journal of Physiology-Heart and Circulatory Physiology 309 (5 …, 2015 | 42 | 2015 |
| Pharmacokinetics, antitumor and cardioprotective effects of liposome-encapsulated phenylaminoethyl selenide in human prostate cancer rodent models JY Kang, M Eggert, S Mouli, I Aljuffali, X Fu, B Nie, A Sheil, K Waddey, ... Pharmaceutical research 32, 852-862, 2015 | 22 | 2015 |
| The cardioprotective mechanism of phenylaminoethyl selenides (PAESe) against doxorubicin-induced cardiotoxicity involves frataxin X Fu, M Eggert, S Yoo, N Patel, J Zhong, I Steinke, M Govindarajulu, ... Frontiers in Pharmacology 11, 574656, 2021 | 12 | 2021 |
| The role of frataxin in doxorubicin‐mediated cardiac hypertrophy (648.6) S Mouli, G Nanayakkara, R Fu, A Berlin, A Alasmari, R Arnold, R Amin The FASEB Journal 28, 648.6, 2014 | 2 | 2014 |
| Balancing the Neuroprotective Versus Neurotoxic Effects of Cannabis S Mouli, S Ramesh, M Govindarajulu, M Almaghrabi, A Fujihashi, ... Medicinal Herbs and Fungi: Neurotoxicity vs. Neuroprotection, 203-226, 2021 | 1 | 2021 |
